Abstract: Obesity constitutes a critical risk factor for the development of many life threatening diseases, particularly insulin resistance and type 2 diabetes. Adipose tissue plays an important role in regulating whole body energy homeostatsis and obesity-related insulin resistance. Infl ammation has been commonly linked to insulin resistance. Recent studies demonstrated that adipose tissue is an important source for producing infl ammatory molecules in the obese state, primarily due to accumulation of macrophages. Animal models defi cient in key infl ammatory molecules or with reduced adipose macrophage infi ltration are protected from development of obesity-related insulin resistance. Repression of adipose infl ammation may be a useful approach to ameliorate obesity-associated metabolic disorders.
Correlation between obesity-related insulin resistance and infl ammation
Approximately 30% of US adults and 20% of school-aged children are obese. Obesity has become an epidemic disease and its incidence is still rapidly increasing at an alarming rate (Hill et al 2003) . The hallmark of obesity is manifested by massive expansion of adipose tissue, attributable to excessive food consumption and sedentary life style in modern society. Obesity has been identifi ed as a major risk factor for the development of many life-threatening diseases, such as hypertension, atherosclerosis, dyslipidemia, and particularly type 2 diabetes (Kopelman 2000) . Type 2 diabetes itself is also a risk factor for the development of heart disease and stroke. As a matter of fact, more than 65% of people with diabetes die from heart disease or stroke. The underlying molecular mechanism for obesity-related metabolic disorders is still not well understood. The correlation between obesity, diabetes and infl ammation have been observed as early as several decades ago, when increased circulating levels of acute phase proteins, such as fi brinogen, haptoglobin, and α-1 antitripsin, were reported (Fearnley et al 1959; Ogston and McAndrew 1964; Ganrot et al 1967) . In more recent studies, elevated serum concentrations of more acute phase proteins were shown, including sialic acid, α-1 acid glycoprotein, C-reactive protein (CRP) and serum amyloid A (Crook et al 1993; Pickup et al 1997) . In addition, infl ammatory proteins such as IL-6 and plasminogen activator inhibitor 1 (PAI-1), as well as increased white cell count are also found to correlate with type 2 diabetes (Festa et al 2002; Pradhan et al 2001; Vozarova et al 2002) . However, fi ndings from these human population studies alone were not suffi cient to stimulate thoughts regarding whether infl ammation could be a causative factor for the pathogenesis of obesity-related insulin resistance and type 2 diabetes.
Recent studies indicate that infl ammatory event in the adipose tissue may play a critical role in the development of insulin resistance. Tumor necrosis factor-α (TNFα) is the fi rst cytokine identifi ed with elevated expression in adipose tissue from obese rodents and humans, resulting from both increased production and abnormal processing (Hotamisligil et al 1993 (Hotamisligil et al , 1995 Xu et al 2002b) . TNFα inhibits signaling from the insulin receptor and neutralization of TNFα by infusion with a tumor necrosis factor receptor-immunoglobin G (TNFR-IgG) chimeric protein improves insulin sensitivity (Feinstein et al 1993; Hotamisligil et al 1993 Hotamisligil et al , 1994 . TNFα can also cause dysregulated lipolysis in adipocytes, therefore potentially contributes to the elevation of circulating free fatty acid (FFA) concentration (Green et al 1994) . FFA has been demonstrated to be a critical factor for causing systemic insulin resistance in multiple tissues, such as liver and muscle. The discovery that infl ammatory cytokine TNFα impairs insulin signaling greatly stimulated the fi eld and scientists started to view that infl ammation may be a causative event for the pathogenesis of obesity-related insulin resistance. Subsequently, more cytokines, chemokines and other secretary proteins are found to increase in adipose tissue of obese rodents and/or humans, including leptin, interleukin-6 (IL-6), IL-8, monocyte chemotactic factor 1 (MCP-1), angiotensinogen, visfatin, resistin, retinol-binding protein-4, serum amyloid A (SAA). Among these molecules, IL-6, IL-8, and MCP-1 have been reported to impair insulin action (Rotter et al 2003; Sartipy and Loskutoff 2003) . The reason that cytokine and chemokine production increases in response to triglyceride accumulation in adipose tissue is not clear. One possibility is that these factors might have designated roles to limit excessive fat mass expansion, which unfortunately is at the cost of inducing insulin resistance. Consistent with this hypothesis, TNFα, IL-8, and MCP-1 have been reported to inhibit adipocyte differentiation (Xu et al 1999; Gerhardt et al 2001; Xu and Hotamisligil 2001) . Animals defi cient in CCR2, the major receptor of MCP-1, have larger adipocytes but are more insulin sensitive (Weisberg et al 2006) . This hypothesis is further supported by two animal models: adipose tissue TNFα transgenic and fat-specifi c insulin receptor knockout mice. Both models demonstrated reduced adiposity but accompanied by severely impaired insulin signaling in adipose tissue (Bluher et al 2002; Xu et al 2002a) . However, the systemic insulin sensitivity has been improved despite adipose insulin resistance, suggesting the importance of overall fat mass on metabolism.
Animal models defi cient in key infl ammatory molecules
Intensive investigations with various animal models defi cient in key molecules in the infl ammatory pathway further provided solid evidence for the causative role of infl ammation in the development of obesity-related insulin resistance.
The fi rst proof of principle animal model is TNFα-defi cient mice. In the absence of TNFα, mice are partially protected from development of hyperlipidymia, hyperglycemia and hyperinsulinemia without an effect on body weight in obesity models induced by high fat diet, defi ciency of leptin, or gold-thioglucose injection (Uysal et al 1997; Ventre et al 1997) . Increased tyrosine phosphorylation of insulin receptor was observed in both adipose tissue and muscle in obese mice defi cient in TNFα. In addition, KB-R7785, a synthetic compound that inhibits TNFα production, can improve insulin sensitivity in obese/diabetic KKA y mice (Morimoto et al 1997) . These in vivo data support a role of TNFα as a candidate mediator of obesity-induced insulin resistance but also indicate the involvement of other factors since the protection is partial. TNFα signals through two receptors, p55 and p75. The role of TNFα receptors in mediating the effect of TNFα on obesity-related insulin resistance is controversial in two independent studies, which might be attributable to differences in genetic backgrounds (Schreyer et al 1998; Uysal et al 1998) .
Recently, the c-Jun NH2-terminal kinase (JNK) has appeared as a vital regulator in obesity and insulin resistance. Both TNFα and FFA are potent stimulators for JNK activation. Indeed, JNK activity is elevated in liver, adipose tissue and muscle in both diet-induced obese mice and ob/ob mice (Hirosumi et al 2002) . Interestingly, different JNK isoforms seem to play distinct roles. JNK1 defi cient mice have decreased adiposity and adipocyte size, increased serum adiponection and lowered serum resistin concentrations, lowered glucose and insulin concentrations, enhanced insulin signaling in the liver and improved whole body insulin sensitivity upon high fat diet (Hirosumi et al 2002) . Absence of JNK1 also partially protected ob/ob mice from developing hyperglycemia and hyperinsulinemia (Hirosumi et al 2002) . In contrast, defi ciency of JNK2 does not have any infl uence on diet-induced insulin resistance. These results demonstrate that JNK1 accounts for the majority of increased JNK activity in insulin target tissues and is an important regulator in obesity-related insulin resistance.
IKKβ, the master regulator of infl ammation which can also be activated by TNFα and FFA, is another important serine kinase involved in the development of obesity-related insulin resistance. Homozygous IKKβ defi ciency is lethal due to increased liver apoptosis but heterozygous IKKβ +/− mice appear normal. Lowered fasting glucose and insulin concentrations were observed in IKKβ +/− mice on both standard diet and high-fat diet compared to wild-type littermates (Yuan et al 2001) . Furthermore, absence of one IKKβ allele is suffi cient
Adipose infl ammation and insulin resistance to lower blood glucose and plasma FFA levels as well as improve glucose tolerance in ob/ob mice (Yuan et al 2001) . Arkan and colleagues (2005) further selectively deleted IKKβ in hepatocytes or myeloid cells and showed that IKKβ deficiency in hepatocytes locally protected liver from development of obesity-related insulin resistance, but fat and muscle still develop insulin resistance upon high fat diet. Consistent with these results, transgenic mice selectively expressing the constitutively active form of IKKβ in the liver have increased hepatic production of proinfl ammatory cytokines, which caused profound hepatic insulin resistance (Cai et al 2005) .
In addition, these proinfl ammatory cytokines also cross talk with other tissues and lead to hyperglycemia, and modest systemic insulin resistance (Cai et al 2005) . Interestingly, specifi c deletion of IKKβ in myeloid cells of diet-induced obese mice or ob/ob mice is suffi cient to improve systemic insulin sensitivity, which is attributable to decreased production of proinfl ammatory cytokines or chemokines that are known to inhibit insulin signaling in cultured cells (Arkan et al 2005) . These data demonstrate that IKKβ plays an important role in the development of obesity-related insulin resistance by acting in multiple cell types, particularly myeloid cells. TLR4, a family member of toll-like receptors (TLRs), plays a critical role in pattern recognition and activation of innate immunity (Medzhitov et al 1997) . Lipopolysaccharide (LPS) is the well characterized ligand for TLR4 (Poltorak et al 1998) . Several recent studies demonstrate that FFAs, whose levels are elevated in obesity, can also activate TLR4 . Defi ciency of TLR4 can prevent FFA-induced production of infl ammatory cytokines in both macrophages and adipocytes. In lipid-infused animals, absence of TLR4 signifi cantly improved insulin signaling in muscle and decreased production of infl ammatory cytokines in adipose tissue (Shi et al 2006) . Absence of TLR4 also modestly improved systemic insulin sensitivity in female mice upon high fat challenge, presumably through reduced production of proinfl ammatory cytokines in liver and adipose tissue. Similar phenotypes are also observed in diet-induced obese mice with a loss-of-function mutation in TLR4, confi rming a role of TLR4 in linking innate immunity and lipid-induced insulin resistance (Tsukumo et al 2007) .
Adipose tissue macrophage accumulation in obesity
Despite the substantive amount of data demonstrating the link between infl ammation and obesity-related insulin resistance, the specifi c cell source for production of infl ammatory molecules are unclear though it appears to be originated from adipose tissue. It was originally thought that adipocytes are the cell type that produces proinfl ammatory factors. It has been shown that adipocytes possess many features of immune cells and adipocyte precursors have phagocytic capacity and can be converted into macrophage-like cells in response to certain stimuli (Cousin et al 1999; Charriere et al 2003) . Two studies in 2003, which used transcription profi ling approach to compare adipose tissue from lean and several rodent obesity models, or adipose tissue from obese animals before and after treatment with compounds of the thiazolidinedione class of anti-diabetic agents, have showed that the majority of genes signifi cantly upregulated in obese adipose tissue are macrophage and infl ammatory genes, which can be repressed by rosiglitazone (Weisberg et al 2003; Xu et al 2003) . By separating adipocytes from stromal-vascular cells and histological examination, these studies revealed massive macrophage accumulation in adipose tissue in the obese state.
Bone marrow transplant study further demonstrated that these macrophages are predominantly infi ltrated, rather than converted from local preadipocytes. Activated macrophages are known to secrete a variety of pro-infl ammatory cytokines and chemokines. In these two studies, isolated stromal-vascular cells, the fraction containing infi ltrated macrophages, are demonstrated to be the predominant source for producing proinfl ammatory molecules in comparison to adipocytes, including TNFα, MCP-1, IKKβ, IL-1β, and inducible nitric oxide synthase (iNOS). These results suggest that infi ltrated macrophages in adipose tissue in state of obesity are likely an important source contributing to elevation of circulating infl ammatory marker proteins. Blood mononuclear cells (MNCs) in the obese state are also reported to be in a proinfl ammatory state, as refl ected by increased nuclear factor kappa-B (NF-κB) binding activity, decreased IκB content and increased transcription of NF-κB controlled proinfl ammatory genes, indicating that infl amed circulating MNCs may also contribute to elevation of circulating infl ammatory marker proteins as well . The triggering factors for macrophage infi ltration into adipose tissue and the roles of infi ltrating macrophages are still not well understood. One speculation is that enlargement of fat cells, which commonly occurs in obese state at relatively early stage, may trigger the initial secretion of critical monocyte chemotactic factors. Once macrophages infi ltrate into adipose tissue and get activated, they become the major source of infl ammatory molecules and continue to attract more macrophages to further amplify the harmful cycle. The prototype monocyte chemotactic factor, MCP-1, has been under intensive investigation as such a candidate for recruiting macrophages into adipose tissue in obesity since its expression is upregulated in adipose tissue in early stage of diet-induced obesity. However, controversial results have been reported for the role of MCP-1. One publication showed that mice defi cient in MCP-1 have partially reduced adipose tissue macrophage accumulation upon high fat diet and are accompanied with improved insulin sensitivity and hepatic steatosis (Kanda et al 2006) . Acute expression of a dominant-negative MCP-1 mutant also ameliorated insulin resistance in both diet-induced obese mice and db/db mice (Kanda et al 2006) . Another publication demonstrated no change of adipose macrophage content in MCP-1 knock out mice (Inouye et al 2007) . These results suggest the roles of other monocyte chemotactic factors. Nevertheless, reports from two independent laboratories reported that mice overexpressing MCP-1 transgene in adipose tissue under the promoter of adipocyte fatty acid binding protein have increased macrophage accumulation in adipose tissue and are insulin resistant (Kamei et al 2006; Kanda et al 2006) . The major receptor of MCP-1 is CCR2, which also mediates signaling of other monocyte chemotactic factors such as MCP-2 and MCP-3. Macrophages recruited into adipose tissue in obese state have increased expression of CCR2. Mice defi cient in CCR2 have a lean phenotype when fed on a high fat diet due to reduced food intake. When high fat-diet fed CCR2 defi cient mice and control mice are matched for adiposity, partially decreased adipose macrophage content was observed. These mice have improved infl ammatory profi le in adipose tissue, along with improved systemic insulin sensitivity and ameliorated hepatic steatosis (Weisberg et al 2006) . DIO mice treated with CCR2 antagonist have a 28% reduction of adipose macrophage content and have improved hyperglycemia (Weisberg et al 2006) . These data suggest that CCR2 plays a role in adipose tissue macrophage recruitment in obese state and also point out the potential role(s) of other chemokine receptor(s) since absence of CCR2 only partially blocked macrophage infi ltration upon high fat diet.
Macrophages are phagocytic cells that clear pathogens, dead cells and cell debris in innate immunity and wound healing. It has been shown that adipocyte death increases signifi cantly in obese humans and mice via the mechanism of necrosis. The majority of infi ltrated macrophages in adipose tissue are localized around dead adipocytes to form crownlike structure (CLS) (Cinti et al 2005) . This scenario highly resembles atherosclerosis, which is caused by macrophage infi ltration into aorta to clean excessive cholesterol and subsequent formation of foam cells. Interestingly, frequency of adipocyte death in epidydimal fat pat correlates with the extent of macrophage infi ltration (Strissel et al 2007) . These data indicate that infi ltrated macrophages are involved in clearance of cell debris, leaked lipids and perhaps are important for adipose tissue remodeling. Macrophages are heterogeneous in function and their properties and activation state are dependent upon local environment factors. Two polarization states, M1 or "classically activated" and M2 or "alternatively activated", have been defi ned for macrophage activation. M1 macrophages have high proinfl ammatory cytokine expression and produce reactive oxygen species; M2 macrophages express high levels of anti-infl ammatory cytokines, such as IL-10. IL-10 can selectively inhibit transcription rates of infl ammatory gene and activate STAT3 to attenuate infl ammatory signals induced by TNFα. Macrophages infi ltrated into adipose tissue in obese state possess features of M1 macrophages and more importantly, macrophages in CLS express protein of TNFα and IL-6 (Lumeng et al 2007; Strissel et al 2007) . In contrast, resident macrophages in adipose tissue of lean mice have many features of M2 macrophages, including expression of M2 macrophage characteristic genes such as Ym1, arginase 1, and IL-10. High fat diet is suffi cient to promote macrophage phenotypic switch from anti-infl ammatory M2 polarization to proinfl ammatory M1 polarization. Peroxisome proliferator activated receptor-γ (PPARγ), the molecular target for the anti-diabetic thiazolidinedione class of compounds, has been reported to play a key role in maturation of alternatively activated macrophages with anti-infl ammatory properties (Bouhlel et al 2007) . Mice defi cient of PPARγ in myeloid cells have impaired activation of M2 macrophages, as demonstrated by decreased expression and activity of arginase, hallmarks of alternatively activated macrophages (Hevener et al 2007; Odegaard et al 2007) . These mice have lower content of alternatively activated macrophages, increased local infl ammation in adipose tissue, impaired insulin signaling in adipose tissue, muscle, and liver on chow diet. These mice are also prone to the development of obesity-related insulin resistance. These results indicate that phenotypic switch from M2 to M1 macrophages are critical for impairing insulin sensitivity.
Transient neutrophil infi ltration into adipose tissue in obesity is also reported, which occurs 3 and 7 days upon high fat diet in epididymal but not subcutaneous fat and disappears on all subsequent times points (Elgazar-Carmon et al 2008) . A potential chemotactic factor for neutrophil infi ltration has been proposed to be IL-8, which can be secreted by adipose tissue in obesity. Neutrophils have been demonstrated to directly adhere to adipocytes and this process can be infl uenced by cations and activation state of neutrophils. The time course of adipose tissue neutrophil infi ltration precedes macrophage infi ltration, which does not start increase till 8 weeks upon high fat diet (Strissel et al 2007) . Neutrophil infi ltration refl ects acute infl ammation while macrophage infi ltration symbols chronic infl ammation. Activated neutrophils can release ROS and TNFα, whether infi ltrated neutrophils contribute to adipose infl ammation remains a question to be studied.
Targeting infl ammation as a potential therapeutic approach for improving insulin sensitivity
The fi ndings for a potential role of adipose infl ammation in the development of insulin resistance from animal models can also be extended to humans. Macrophage accumulation has been observed in human adipose tissue and the extent has strong positive correlation with BMI and adipocyte area but negatively related to insulin sensitivity (Weisberg et al 2003) . The macrophage content is depot dependent. Omental fat of obese humans contains more macrophages than subcutaneous fat. Omental fat macrophage infi ltration correlates to fasting glucose, insulin and hepatic fi broinfl ammatory lesions in obese patients (Cancello et al 2006) . In addition, obese subjects with impaired glucose homeostasis have preferential omental adipose macrophage infi ltration (Harman-Boehm et al 2007) . Weight loss in obese subjects either through low calorie diet or bariatric surgery have decreased expression of infl ammatory factors and increased expression of anti-infl ammatory molecules, accompanied with decreased macrophage number and improved metabolic profi le (Clement et al 2004; Cancello et al 2005) . These data suggest that anti-infl ammatory reagents or blockage of macrophage infi ltration into adipose tissue may be benefi cial for improving systemic insulin resistance in obese patients.
Infl ammation has been generally correlated with insulin resistance in many situations, such as trauma, burn and infection. Although it is a relatively recent fi nding that adipose infl ammation is associated with obesity-related insulin resistance, the effect of anti-infl ammation reagent sodium salicylate on improving symptoms of diabetes mellitus was demonstrated a century ago (Williamson 1901) . Later on, high dose aspirin was discovered to not only improve arthritis in a diabetic patient, but also make daily insulin injection unnecessary for controlling blood glucose level (Reid et al 1957) . Cessation of aspirin upon disappearance of joint symptoms caused recurrence of glucose intolerance. Subsequent clinical trial with high dose-aspirin reconfi rmed the effect on lowering blood glucose levels (Hecht and Goldner 1959) . The molecular target mediating the hypoglycemic effect of salicylates has now been identifi ed, which is IKKβ (Yuan et al 2001) . IKKβ activates NF-κB, which is a master transcription factor that activates transcription of numerous infl ammatory genes. Potent small molecule inhibitor aginst IKKβ may be benefi cial for improving insulin reistance in obese subjects.
Another line of evidence that repression of inflammation may be useful for controlling hyperglycemia in type 2 diabetic patients derives from the anti-infl ammatory effect of the widely used insulin sensitizer. Thiazolidinediones (including rosiglitazone and pioglitazone), a new and highly effi cacious class of insulin-sensitizing drugs that mainly targeting adipose tissue by activating PPARγ, have been reported to have anti-infl ammatory effect. PPARγ is a ligand-dependent nuclear hormone receptor predominantly expressed in adipocyte and is a master regulator of adipocyte differentiation. Expression of PPARγ is signifi cantly increased upon macrophage activation and treatment with thiazolidinediones inhibits production of monocyte infl ammatory cytokines and expression of iNOS, gelatinase B and scavenger genes, partly through repressing the activities of transcription factors AP-1, STAT, and NF-κB. In animal models, PPARγ agonists have been reported to improve development of atherosclerosis (Li et al 2000; Stojanovska et al 2007) . These results indicate that thiazolidinediones can repress macrophage-mediated infl ammation. Interestingly, atherosclerosis-prone apolipoprotein E-defi cient mice transplanted with infl amed visceral fat developed signifi cantly more atherosclerosis compared to sham-operated animals. Treatment with pioglitazone decreased macrophage content of the transplanted visceral fat tissue, reduced plasma MCP-1 and reduced atherosclerosis (Ohman et al 2008) . Ten-week treatment with pioglitazone in subjects with impaired glucose tolerance reduced macrophage number in adipose tissue and decreased infl ammatory cytokine production (Di Gregorio et al 2005) . Furthermore, thiazolidinediones are also reported to suppress NF-κB activity in infl amed circulating MNCs in obese subjects (Ghanim et al 2001 (Ghanim et al , 2006 Mohanty et al 2004) . These results suggest that the insulin sensitizing effect of thiazolidinediones could be partially achieved through repression of adipose tissue macrophage content and subsequent reduction of infl ammatory factor production.
In summary, substantive evidence derived from both animal models and human studies supports an important role of adipose infl ammation in the development of obesityrelated insulin resistance. Development of new therapeutic agents targeting improving adipose infl ammation, such as blocking macrophage infi ltration and preventing phenotypic switch of M2 to M1 macrophages, may be effective for attenuating insulin resistance and hyperglycemia associated with obesity.
Disclosure
The authors report no confl icts of interest in this work.
